Study guide
9.6 Medication, Culture, and Continuing Care
IC&RC Alcohol and Drug Counselor CADC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Orientation, IC&RC ADC Exam, and Credential Path
1.1 ADC Credential, IC&RC, and CADC Naming 1.2 Administering Board Application Workflow 1.3 Minimum Standards and Eligibility Boundaries 1.4 ADC Blueprint and Study Priorities 1.5 Exam Format, Items, and Time Management 1.6 Scores, Results, Retakes, and Remediation 1.7 Exam-Day Admission, In-Person Testing, and Remote Testing
2 Chapter 2: Addiction Science, Substance-Use Patterns, and Risk Factors
2.1 Disease Model and Biopsychosocial Frame 2.2 Reward Pathways, Learning, and Reinforcement 2.3 Tolerance, Withdrawal, Craving, and Cross-Tolerance 2.4 Substance-Use Progression and Severity Patterns 2.5 Risk and Protective Factors Across the Lifespan 2.6 Prevention, Case Conceptualization, and Domain Integration
3 Substance Classes, Intoxication, Overdose, and Withdrawal
3.1 Alcohol Intoxication, Overdose, and Withdrawal 3.2 Sedatives, Hypnotics, Anxiolytics, and Cross-Tolerance 3.3 Opioids: Intoxication, Overdose, and Withdrawal 3.4 Stimulants: Intoxication, Crash, and Crisis Risk 3.5 Cannabis, Hallucinogens, and Inhalants 3.6 Polysubstance Use and Overdose Triage
4 Co-Occurring Mental Health, Medical, and Trauma Concerns
4.1 Co-Occurring Symptoms and Integrated Screening 4.2 Suicide, Self-Harm, and Crisis Triage 4.3 Medical Red Flags and Substance-Related Health Concerns 4.4 Trauma-Informed Care and ACEs 4.5 Special Populations, Developmental, and Cultural Factors 4.6 Scope, Referral, Collaboration, and Documentation
5 Screening, Interviewing, and Assessment Instruments
5.1 Motivational Assessment Interview Stance 5.2 Screening Purpose and Instrument Selection 5.3 Substance-Use History and Pattern Exploration 5.4 Collateral Information and Testing Interpretation 5.5 Risk, Withdrawal, and Immediate Needs Screening 5.6 Engagement, Culture, and Documentation
6 Diagnosis, Biopsychosocial Assessment, and Level of Care
6.1 Diagnostic Concepts and Scope 6.2 Biopsychosocial Assessment Framework 6.3 Immediate and Ongoing Needs 6.4 Level-of-Care Placement Reasoning 6.5 Case Formulation and Assessment Summary 6.6 Documentation, Referral, and Reassessment
7 Counseling Relationship, Communication, and Motivational Interviewing
7.1 Rapport and the Working Alliance 7.2 Core Communication Skills 7.3 OARS and Reflective Listening 7.4 Ambivalence, Resistance, and Discord 7.5 Change Talk and Stages of Change 7.6 Feedback and Counselor Style
8 Treatment Planning, Case Management, and Referral
8.1 Treatment Plan Anatomy 8.2 Individualized Goals and Objectives 8.3 Relapse Prevention and Continuing Care 8.4 Case Management and Resource Linkage 8.5 Referral and Multidisciplinary Collaboration 8.6 Discharge, Termination, and Continuity of Care
9 Group Counseling, Family Work, and Recovery Pathways
9.1 Group Purpose, Screening, and Norms 9.2 Group Stages, Cohesion, and Facilitation Skills 9.3 Psychoeducation, Skills Groups, and Process Groups 9.4 Family and Support-System Collaboration 9.5 Mutual Help, Peer Support, and Recovery Pathways 9.6 Medication, Culture, and Continuing Care
10 Professional Ethics, Boundaries, and Scope of Practice
10.1 Ethical Frameworks and Decision Making 10.2 Boundaries, Dual Relationships, and Power 10.3 Self-Disclosure, Conflicts of Interest, and Gifts 10.4 Scope of Practice, Competence, and Referral 10.5 Supervision, Consultation, and Team Accountability 10.6 Self-Awareness, Impairment, and Burnout
11 Confidentiality, Documentation, Informed Consent, and Client Rights
11.1 Confidentiality Foundations for ADC Practice 11.2 Releases and Minimum Necessary Disclosure 11.3 Documentation and Record Quality 11.4 Informed Consent and Client Rights 11.5 Mandated Reporting and Safety Exceptions 11.6 Grievances, Records, Storage, and Professional Communication
12 Integrated CADC Case Scenarios and Final Review
12.1 Reading Integrated Case Vignettes 12.2 Blueprint-Weighted Final Review 12.3 Integrated Scenario: First Contact Through Assessment 12.4 Integrated Scenario: Treatment, Referral, and Discharge 12.5 Weak-Domain Remediation and 8-12 Week Study Plan 12.6 Exam Day, Results, and Retake Workflow
9.6 Medication, Culture, and Continuing Care
Key Takeaways Explain This Topic AI
Medications for opioid use disorder — methadone, buprenorphine, naltrexone — are evidence-based; methadone and buprenorphine cut overdose death risk by about half.
The CADC supports medication adherence and counters stigma but never prescribes, adjusts doses, or gives medical advice outside scope.
Twelve-step culture has historically been ambivalent toward MOUD; the counselor helps clients find recovery-supportive settings.
Culturally responsive continuing care matches resources to the client's identity, language, values, and access barriers.
Continuing-care planning maps relapse warning signs, supports, and follow-up across personal, social, and community recovery capital.
Last updated: June 2026
Medications for Addiction Treatment
Medications for opioid use disorder (MOUD) — sometimes still called MAT — are among the most evidence-based interventions in the field, and combining them with counseling and recovery support is the standard of care. The FDA approves three:
Medication Mechanism Notes
Methadone Full opioid agonist Reduces cravings/withdrawal; dispensed through opioid treatment programs; cuts overdose death risk
Buprenorphine (e.g., Suboxone with naloxone) Partial opioid agonist; ceiling effect Office-based; lower overdose risk; cuts overdose death risk
Naltrexone (oral / Vivitrol injection) Opioid antagonist; blocks effects Requires full detox first; non-opioid
Methadone and buprenorphine reduce overdose deaths by roughly 50% versus no medication. For alcohol use disorder, FDA-approved options include naltrexone (reduces craving and heavy drinking), acamprosate (supports abstinence by stabilizing brain chemistry, best for already-abstinent clients), and disulfiram (Antabuse, which causes an unpleasant reaction if alcohol is consumed and depends on adherence). Each works differently and is chosen with the prescriber based on the client's goals and history.
The exam-critical boundary: the CADC does not prescribe, change doses, diagnose, or give medical advice . The counselor supports adherence, monitors for side effects to report to the prescriber, integrates medication into the recovery plan, and coordinates with the qualified medical provider — staying firmly within scope.
Stigma and Medication-Supported Recovery
A recurring exam theme is stigma against medication-supported recovery . Historically, some abstinence-oriented mutual-aid cultures have viewed people on methadone or buprenorphine as "not really clean," and clients on MOUD may feel unwelcome in certain twelve-step rooms. Narcotics Anonymous literature has reflected an abstinence ideal, and members on agonist medications have reported a "chilly reception," though attitudes vary widely by meeting and many groups are explicitly MOUD-friendly. Programs like Medication-Assisted Recovery Anonymous (MARA) and many SMART Recovery meetings welcome MOUD.
The high-scoring counselor response is to affirm that medication-supported recovery is legitimate recovery , help the client find welcoming meetings or peer supports, and never echo the stigma. Treating MOUD as a moral failing — or pressuring a client to taper off medication against medical advice to satisfy a program's culture — is both clinically harmful and outside the counselor's scope. The counselor's stance is client choice plus coordination with the prescriber, not judgment.
Cultural Responsiveness and Continuing Care
Culturally responsive care means matching recovery resources to the client's identity, language, values, spiritual orientation, and lived context, and recognizing access barriers — transportation, cost, immigration concerns, work schedules, child care, discrimination — that shape whether a referral actually works. A technically appropriate referral the client cannot reach is not a real plan.
, Wellbriety and the Medicine Wheel/12 Steps for Native communities, faith-based recovery in some Black and Latino communities, language-specific meetings, LGBTQ+-affirming groups) improve engagement and retention.
Continuing care (aftercare) extends support after a primary level of care ends and is where relapse prevention becomes concrete. A solid continuing-care plan:
- Identifies the client's relapse warning signs and a written response plan
- Lists mutual-aid and peer supports (which meetings, when, with whom)
- Names family/support people and any safety considerations
- Specifies medical follow-up and medication management
- Addresses recovery capital — housing, employment, education, recovery community
- Sets follow-up contacts and a step back up to a higher level of care if needed
Continuity of care is itself an exam-tested value: recovery is a long-term process, and the counselor's job is to hand the client off to durable supports rather than to discharge into a vacuum. The strongest exam answers support client choice, match resources to culture and access reality, and coordinate with qualified providers across the continuum.
Levels of Care, Recovery-Oriented Systems, and a Worked Scenario
Continuing care is best understood against the ASAM Criteria continuum of levels of care (roughly 0.5 early intervention, 1 outpatient, 2 intensive outpatient/partial hospitalization, 3 residential, and 4 medically managed inpatient). Recovery typically means stepping down through these levels as the client stabilizes — and being willing to step back up if risk rises. The counselor uses the six ASAM assessment dimensions (including dimension 6, recovery environment) to decide where a client should be, and continuing care is the bridge between formal treatment and community-based support.
The field increasingly frames this as a recovery-oriented system of care (ROSC) — a coordinated network of clinical treatment, MOUD, peer support, mutual aid, recovery housing, employment and education services, and community resources, organized around the person and sustained over time rather than a single episode of acute care.
A worked scenario pulls the section together. A client completing intensive outpatient is stable on buprenorphine. The continuing-care plan steps the client down to weekly outpatient counseling, schedules medical follow-up with the prescriber, names a MOUD-friendly mutual-aid meeting and a peer recovery specialist, identifies recovery housing to strengthen the recovery environment, documents the client's personal relapse warning signs with a written response plan, and lists supportive family contacts (with consent).
It matches resources to the client's language and culture and removes a transportation barrier with a bus pass. The counselor counters any MOUD stigma the client encounters and coordinates — never overriding — the prescriber's medical decisions. This integrated, client-centered, scope-respecting plan, built on personal, social, and community recovery capital, is precisely what the CADC exam expects for sustaining recovery after discharge.